nortilidine has been researched along with voriconazole in 1 studies
| Studies (nortilidine) | Trials (nortilidine) | Recent Studies (post-2010) (nortilidine) | Studies (voriconazole) | Trials (voriconazole) | Recent Studies (post-2010) (voriconazole) |
|---|---|---|---|---|---|
| 17 | 7 | 6 | 4,390 | 219 | 2,678 |
| Protein | Taxonomy | nortilidine (IC50) | voriconazole (IC50) |
|---|---|---|---|
| Cytochrome P450 2C9 | Homo sapiens (human) | 8.4 | |
| Cytochrome P450 2C19 | Homo sapiens (human) | 8.7 | |
| Cholesterol 24-hydroxylase | Homo sapiens (human) | 0.0345 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Grün, B; Krautter, S; Mikus, G; Riedel, KD | 1 |
1 trial(s) available for nortilidine and voriconazole
| Article | Year |
|---|---|
Inhibition of the active principle of the weak opioid tilidine by the triazole antifungal voriconazole.
Topics: Adult; Analgesics, Opioid; Analysis of Variance; Antifungal Agents; Aryl Hydrocarbon Hydroxylases; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP3A; Double-Blind Method; Drug Interactions; Female; Humans; Male; Middle Aged; Pyrimidines; Tilidine; Triazoles; Voriconazole; Young Adult | 2009 |